CL2015003420A1 - Métodos para producir partículas que comprenden proteínas terapeuticas - Google Patents

Métodos para producir partículas que comprenden proteínas terapeuticas

Info

Publication number
CL2015003420A1
CL2015003420A1 CL2015003420A CL2015003420A CL2015003420A1 CL 2015003420 A1 CL2015003420 A1 CL 2015003420A1 CL 2015003420 A CL2015003420 A CL 2015003420A CL 2015003420 A CL2015003420 A CL 2015003420A CL 2015003420 A1 CL2015003420 A1 CL 2015003420A1
Authority
CL
Chile
Prior art keywords
methods
therapeutic proteins
producing particles
particles
producing
Prior art date
Application number
CL2015003420A
Other languages
English (en)
Inventor
Sarah Marquette
Andrew Yates
Claude Peerboom
Original Assignee
Ucb Biopharma Sprl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50877246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015003420(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP13168674.3A external-priority patent/EP2805708A1/en
Application filed by Ucb Biopharma Sprl filed Critical Ucb Biopharma Sprl
Publication of CL2015003420A1 publication Critical patent/CL2015003420A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

MÉTODO PARA PRODUCIR PARTÍCULAS QUE COMPRENDEN UNA MATRIZ DE POLÍMERO Y PROTEÍNAS TERAPEUTICAS
CL2015003420A 2013-05-22 2015-11-20 Métodos para producir partículas que comprenden proteínas terapeuticas CL2015003420A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13168674.3A EP2805708A1 (en) 2013-05-22 2013-05-22 Methods to produce particles comprising therapeutic proteins
EP14161988 2014-03-27

Publications (1)

Publication Number Publication Date
CL2015003420A1 true CL2015003420A1 (es) 2016-09-30

Family

ID=50877246

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015003420A CL2015003420A1 (es) 2013-05-22 2015-11-20 Métodos para producir partículas que comprenden proteínas terapeuticas

Country Status (14)

Country Link
US (1) US20160090415A1 (es)
EP (1) EP2999459A1 (es)
JP (1) JP2016519152A (es)
KR (1) KR20160009690A (es)
CN (1) CN105338961A (es)
AU (1) AU2014270439A1 (es)
BR (1) BR112015028986A2 (es)
CA (1) CA2912730A1 (es)
CL (1) CL2015003420A1 (es)
EA (1) EA201592222A1 (es)
HK (1) HK1214964A1 (es)
MX (1) MX2015015899A (es)
SG (1) SG11201509450QA (es)
WO (1) WO2014187863A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019528248A (ja) 2016-07-18 2019-10-10 ティシュージェン， インク． 生体分子の立体配座及び構造健全性を維持するための方法及び組成物
CN112336873B (zh) * 2020-08-04 2022-04-19 华南理工大学 用于多特异性抗体递送的蛋白型纳米颗粒及其应用、制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100201352B1 (ko) * 1995-03-16 1999-06-15 성재갑 단일주사 백신 제형
EP2044934A1 (en) * 2007-10-01 2009-04-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Dispersion of poloxamer-protein particles, methods of manufacturing and uses thereof

Also Published As

Publication number Publication date
CN105338961A (zh) 2016-02-17
EP2999459A1 (en) 2016-03-30
JP2016519152A (ja) 2016-06-30
CA2912730A1 (en) 2014-11-27
WO2014187863A1 (en) 2014-11-27
HK1214964A1 (zh) 2016-08-12
US20160090415A1 (en) 2016-03-31
AU2014270439A1 (en) 2015-12-17
EA201592222A1 (ru) 2016-08-31
SG11201509450QA (en) 2015-12-30
BR112015028986A2 (pt) 2017-07-25
KR20160009690A (ko) 2016-01-26
MX2015015899A (es) 2016-07-15

Similar Documents

Publication Publication Date Title
ES2855224T8 (es) Un sistema y método para generar un archivo de audio
EP3047383A4 (en) Method for screen mirroring and source device thereof
CL2015001929A1 (es) Sistema y método optico para seleccionar semillas
EP3013291A4 (en) Systems and methods for a tinnitus therapy
UY34782A (es) Anticuerpos humanos para fel d1 y métodos para usarlos.
BR112015005456A2 (pt) aparelho e método para fornecer capacidades melhoradas de downmix guiado para áudio 3d
BR112015030351A2 (pt) método e aparelho para realização de transações locais
EP3037988A4 (en) CONFIGURATION PROCESS AND DEVICE FOR A HASH DATABASE
BR112015011262A2 (pt) artigo absorvente e método para produzir um artigo absorvente
HK1220173A1 (zh) 調節劑和與其相關的方法
HK1220180A1 (zh) 調節劑及與其相關的方法
EP3035224A4 (en) Method for verifying integrity of dynamic code using hash
GB201519798D0 (en) Boronated biopolymer crosslinking agents and methods relating thereto
EP3005511A4 (en) Method and apparatus for determining time-varying limitations of a power source
BR112015014952A2 (pt) homogeneizador de alta pressão e processo de homogeneização
BR112016008458A2 (pt) embalagem de cápsulas de uso único, máquina para embalar e método para embalar
SG10201405683YA (en) Emission Source And Method Of Forming The Same
BR112013024363A2 (pt) método, e aparelho
HK1216886A1 (zh) 調節劑和與其相關的方法
IL234729A0 (en) A light source operated on a Yidel laser and a method using a mode mixer
EP3136578A4 (en) Power source management method and power source
EP3042500A4 (en) Metadata-based file-identification systems and methods
UY34127A (es) ?zapato con plantilla reconfigurable y método
EP3070933A4 (en) FILE GENERATION METHOD AND FILE GENERATION APPARATUS
CL2015003420A1 (es) Métodos para producir partículas que comprenden proteínas terapeuticas